RecruitingNCT03797183

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

The Associations Between EIT and Clinical Measures During Standard of Care Procedures in Patients With Respiratory Disease: A Preliminary Study

Sponsor

University of Colorado, Denver

Enrollment

90 participants

Start Date

May 3, 2019

Study Type

OBSERVATIONAL

Conditions

Healthy Chronic Respiratory Disease Neuromuscular Diseases Premature Infant Bronchopulmonary Dysplasia Pulmonary Vein Stenoses

Summary

The purpose of this study is to evaluate the Genesis Electrical Impedance Tomography (EIT) imaging system for use in pediatric respiratory disease populations including neuromuscular and bronchopulmonary dysplasia, as well as in age and height matched controls. The EIT does not use radiation, and is read through electrodes.

Eligibility

Min Age: 14 DaysMax Age: 40 Years

Inclusion Criteria7

weeks old - 40 years old
Premature infants with current age \>2 weeks with a confirmed diagnosis of BPD based on NIH criteria
Or Chronic respiratory disease due to underlying neuromuscular disease
Or confirmed neuromuscular disease with an echo completed within the preceding 12 months of study participation of DMD or other diagnoses associated with mild cardiomyopathy.
have had a VQ scan
will be undergoing cardiac catherization for for pulmonary vein stenosis, pulmonary hypertension and/or pulmonary artery stenosis
Or healthy controls

Exclusion Criteria10

\<2 weeks of age
Congenital diaphragmatic hernia
Severe congenital heart disease
Significant genetic abnoralities
Anything that interferes with lead placement on the chest wall
Unwilling/refusal to sign consent
Pregnant or lactating
Pacemaker of other surgical implant and spinal implant (causes noise in the data)
Moderate to severe cardiomyopathy
Patients with temporary cognitive disability due to illness

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.